Literature DB >> 34359981

The Complement System: A Powerful Modulator and Effector of Astrocyte Function in the Healthy and Diseased Central Nervous System.

Marcela Pekna1,2,3, Milos Pekny4,2,3.   

Abstract

The complement system, an effector arm of the innate immune system that plays a critical role in tissue inflammation, the elimination of pathogens and the clearance of dead cells and cell debris, has emerged as a regulator of many processes in the central nervous system, including neural cell genesis and migration, control of synapse number and function, and modulation of glial cell responses. Complement dysfunction has also been put forward as a major contributor to neurological disease. Astrocytes are neuroectoderm-derived glial cells that maintain water and ionic homeostasis, and control cerebral blood flow and multiple aspects of neuronal functioning. By virtue of their expression of soluble as well as membrane-bound complement proteins and receptors, astrocytes are able to both send and receive complement-related signals. Here we review the current understanding of the multiple functions of the complement system in the central nervous system as they pertain to the modulation of astrocyte activity, and how astrocytes use the complement system to affect their environment in the healthy brain and in the context of neurological disease.

Entities:  

Keywords:  C3; astrocytes; neural plasticity; neurodegeneration; reactive astrocytes; reactive gliosis; the complement system

Year:  2021        PMID: 34359981     DOI: 10.3390/cells10071812

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  7 in total

1.  Astrocyte Responses to Complement Peptide C3a are Highly Context-Dependent.

Authors:  Marcela Pekna; Sumen Siqin; Yolanda de Pablo; Anna Stokowska; Åsa Torinsson Naluai; Milos Pekny
Journal:  Neurochem Res       Date:  2022-09-12       Impact factor: 4.414

Review 2.  TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications.

Authors:  Jian Luo
Journal:  Biomedicines       Date:  2022-05-23

3.  C3a Receptor Signaling Inhibits Neurodegeneration Induced by Neonatal Hypoxic-Ischemic Brain Injury.

Authors:  Andrea Pozo-Rodrigálvarez; YiXian Li; Anna Stokowska; Jingyun Wu; Verena Dehm; Hana Sourkova; Harry Steinbusch; Carina Mallard; Henrik Hagberg; Milos Pekny; Marcela Pekna
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

4.  Diet-induced weight loss in obese/diabetic mice normalizes glucose metabolism and promotes functional recovery after stroke.

Authors:  Dimitra Karampatsi; Alexander Zabala; Ulrika Wilhelmsson; Doortje Dekens; Ellen Vercalsteren; Martin Larsson; Thomas Nyström; Milos Pekny; Cesare Patrone; Vladimer Darsalia
Journal:  Cardiovasc Diabetol       Date:  2021-12-22       Impact factor: 9.951

Review 5.  Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury.

Authors:  Marcela Pekna; Anna Stokowska; Milos Pekny
Journal:  Neurochem Res       Date:  2021-08-11       Impact factor: 3.996

6.  Divergent complement system activation in two clinically distinct murine models of multiple sclerosis.

Authors:  Michael Linzey; Krista DiSano; Nora Welsh; Andrew Pachner; Francesca Gilli
Journal:  Front Immunol       Date:  2022-07-26       Impact factor: 8.786

7.  Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy.

Authors:  Feng Wu; Yiding Zhang; Wen Cui; Yijun Dong; Yingyang Geng; Changhao Liu; Zemeng Li; Yandong Xie; Xiaojing Cai; Jin Shang; Jing Xiao; Zhanzheng Zhao
Journal:  Sci Rep       Date:  2021-09-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.